| scholarly article | Q13442814 |
| P50 | author | Stephen Faraone | Q7609174 |
| Stephen J Glatt | Q42305961 | ||
| P2093 | author name string | Thomas J Spencer | |
| Scott H Kollins | |||
| David Goodman | |||
| P2860 | cites work | A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes | Q28269430 |
| The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
| Pharmacotherapy of attention deficit hyperactivity disorder | Q33837448 | ||
| The worldwide prevalence of ADHD: is it an American condition? | Q33999177 | ||
| Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults | Q34431735 | ||
| Form of empirical ROCs in discrimination and diagnostic tasks: implications for theory and measurement of performance | Q39730816 | ||
| Genetics of attention deficit hyperactivity disorder | Q40120994 | ||
| Statistical approaches to the analysis of receiver operating characteristic (ROC) curves | Q40221020 | ||
| Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder | Q42598732 | ||
| Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder | Q43753661 | ||
| A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder | Q43903323 | ||
| A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder | Q44092358 | ||
| Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. | Q46243617 | ||
| Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study | Q48464426 | ||
| Pharmacogenetics of methylphenidate response in preschoolers with ADHD. | Q50922703 | ||
| Indices of discrimination or diagnostic accuracy: their ROCs and implied models. | Q52652943 | ||
| Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder | Q57400056 | ||
| Sensitivities and specificities of diagnostic tests | Q70406993 | ||
| Measuring gain in the evaluation of medical technology. The probability of a better outcome | Q77629615 | ||
| Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study | Q80613425 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 118-127 | |
| P577 | publication date | 2011-04-28 | |
| P1433 | published in | Journal of Attention Disorders | Q15710126 |
| P1476 | title | Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study | |
| P478 | volume | 16 |
| Q38261911 | Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD. |
| Q22241445 | Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants |
| Q52301303 | [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents]. |
Search more.